TREM2 and Alzheimer disease: We exposed monocytes isolated from PBMCs of healthy individuals genotyped for CD33 and SPI1 AD risk variants to aggregated Aβ1-42 in vitro for 24 h and measured surface TREM2 expression with flow cytometry.